EP
NUVA

Eversept Partners’s NuVasive, Inc. NUVA Stock Holding History

Eversept Partners’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-91,798
Closed -$5.37M – 67
2019
Q2 		$5.37M Sell
91,798
-238,803
-72% -$14.1M 1.5% 18
2019
Q1 		$18.8M Buy
+330,601
New +$17.6M 5.48% 6

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Eversept Partners's NUVA Position: Q3 2019 in Review

Eversept Partners sold out of NuVasive, Inc. (NUVA) in Q3 2019, closing a stake of 91,798 shares — an estimated $5.37M sold.

Eversept Partners first reported a position in NUVA in Q1 2019 and held it in 2 quarters. The position peaked at $18.8M in Q1 2019. 262 funds tracked by Wall St. Rank hold NUVA as of Q3 2019.

  • Eversept Partners reported no remaining NuVasive, Inc. position as of Q3 2019 after selling out during the quarter.
  • Eversept Partners sold 91,798 NuVasive, Inc. shares in Q3 2019, an estimated $5.37M.
  • Eversept Partners first reported a position in NuVasive, Inc. in Q1 2019 and held it in 2 quarters.
  • Eversept Partners's NuVasive, Inc. position peaked at $18.8M in Q1 2019.
  • 262 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2019.

Based on Eversept Partners's 13F filing for Q3 2019, filed 13 Nov 2019.